SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-17-002488
Filing Date
2017-10-23
Accepted
2017-10-23 17:10:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13da106922aur_10232017.htm SC 13D/A 111776
2 JOINT FILING AGREEMENT ex991to13da106922aur_102317.htm EX-99.1 4191
  Complete submission text file 0000921895-17-002488.txt   117228
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Filed by) CIK: 0001055919 (see all company filings)

Type: SC 13D/A

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Subject) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88628 | Film No.: 171149496
SIC: 2834 Pharmaceutical Preparations